²é¿´: 2832  |  »Ø¸´: 8

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] Nesina¡¢Kynamro¡¢PomalystÈý¸öÐÂÒ©¼ò½é ÒÑÓÐ6È˲ÎÓë

¿Ú·þ½µÌÇÒ©£ºNesina (Alogliptin)Ƭ(2013-01-25)
ÉÌÆ·Ãû£ºNesina  Í¨ÓÃÃû£ºAlogliptin  ÖÐÎÄÃû£º°¢¸ñÁÐÍ¡
ÉóÅú·ÖÀࣺ±ê×¼ÉóÆÀ
Ò©Æó£ºTakeda Pharmaceuticals
ÊÊÓ¦Ö¢£ºÓÃÓÚÖÎÁƳÉÄ껼ÕßµÄIIÐÍÌÇÄò²¡£¨type 2 diabetes mellitus£©£¬²»ÊÊÓÃÓÚIÐÍÌÇÄò²¡¡£
¼ÁÐ͹æ¸ñ£º±¾Æ·ÊÇÍÖÔ²Á½ÃæÍ¹ÐΡ¢°üÒÂÆ¬£¬ÓÐ25mg/Ƭ¡¢12.5mg/Ƭ¡¢6.25mg/ƬÈýÖÖ¹æ¸ñ£¬·Ö±ðΪdzºìÉ«¡¢»ÆÉ«¡¢Ç³·ÛÉ«£¬ÆäÖÐÒ»ÃæÓ¡ÓÐTAK ALG-25¡¢TAK ALG-12.5¡¢TAK ALG-6.25×ÖÑù¡£ÍƼö25mg/Ì죬·¹Ç°»ò·¹ºó·þÓã¬Çá¶ÈÉö¹¦ÄÜÊÜËð»¼Õߣ¨CrCl¡Ý60mL/min£©ÎÞÐèµ÷Õû¼ÁÁ¿£¬ÖжÈÉö¹¦ÄÜÊÜËð»¼Õߣ¨30¡ÜCrCl<60mL/min£©Ò˵÷ÕûΪ12.5mg/Ìì£¬ÖØ¶ÈÉö¹¦ÄÜÊÜËð»¼Õߣ¨15¡ÜCrCl<30mL/min£©»òÖÕÄ©ÆÚÉö²¡£¨end-stage renal disease£©Ò˵÷ÕûΪ6.25mg/Ìì¡£
»îÐԳɷ֣ºAlogliptin¡£±¾Æ·²ÉÓÃAlogliptin±½¼×ËáÑÎÐÎʽ£¬³Ê°×É«»ò»Ò°×É«¡£

×÷ÓûúÀí£ºÈ˽øÊ³ºó£¬Ð¡³¦»á·ÖÃÚ³¦´ÙÒȵºËØ·ÖÃÚ¼¤ËØ£¨incretin hormones£©ÀýÈçGLP-1¡¢GIP½øÈëѪҺѭ»·£¬´Ì¼¤Òȵº¦Âϸ°û·ÖÃÚÒȵºËØ£¬GLP-1»¹ÄÜÒÖÖÆÒȵº¦Áϸ°û·ÖÃÚÒȸßѪÌÇËØ£¬´Ó¶ø½µµÍ¸ÎÌÇÊä³ö¡£È»ºóÕâЩincretin hormonesÔÚÌåÄںܿ챻DPP-4ø½µ½âʧ»î£¬AlogliptinÄÜÑ¡ÔñÐÔÒÖÖÆDPP-4£¨²»ÒÖÖÆDPP-8¡¢DPP-9£©£¬Ôö¼ÓѪҺÖÐincretin hormonesŨ¶È£¬´Ó¶ø½µµÍIIÐÍÌÇÄò²¡»¼ÕߵĿո¹ºÍ²ÍºóѪÌÇˮƽ¡£
²»Á¼·´Ó¦£º³öÏÖ¸ÅÂÊ´óÓÚ4%µÄ²»Á¼·´Ó¦ÓбÇÑÊÑ×£¨4.4%£©¡¢Í·Í´£¨4.2%£©¡¢ÉϺôÎüµÀ¸ÐȾ£¨4.2%£©£¬ÁíÍ⻼ÕßÈç¹û³öÏÖÒÈÏÙÑ×£¨0.2%£©£¬Ó¦Á¢¼´Í£Ö¹ÓÃÒ©¡£
²¹³ä˵Ã÷£ºÔçÔÚ2010Äê4Ô£¬Nesina±ã»ñµÃÈÕ±¾ºñÉúÀͶ¯Ê¡Åú×¼ÉÏÊС£½üÄêÈ«Çò»ñÅúµÄDPP-4ÒÖÖÆ¼Á»¹ÓÐSitagliptin (Januvia, Merck, 2006), Vildagliptin (Galvus, Novartis, 2008), Saxagliptin (Onglyza, Bristol-Myers Squibb, 2009),  Linagliptin (Trajenta, Boehringer Ingelheim, 2011), Gemigliptin (Zemiglo, LG Life Sciences, 2012), Teneligliptin (Tenelia, Mitsubishi Tanabe, 2012)Áù¸öÆ·ÖÖ¡£

[ Last edited by ³ÕÃÎäìÏæ on 2013-2-16 at 11:23 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ÐÂÒ©·¢ÏÖ ÐÂÒ©Ñз¢

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


½µÖ¬¸¨ÖúÒ©£ºKynamro (Mipomersen sodium)×¢ÉäÒº£¨2013-01-29£©
ÉÌÆ·Ãû£ºKynamro  Í¨ÓÃÃû£ºMipomersen sodium  ÖÐÎÄÃû£ºÎ´Öª
ÉóÅú·ÖÀࣺ±ê×¼ÉóÆÀ
Ò©Æó£ºGenzyme Corp.
ÊÊÓ¦Ö¢£ºÓÃÓÚ½µµÍ´¿ºÏ×ÓÐͼÒ×åÐԸߵ¨¹Ì´¼ÑªÖ¢£¨homozygous familial hypercholesterolemia, FoFH£©»¼ÕߵĵÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼£¨LDL-C£©¡¢ÔØÖ¬µ°°×B£¨apo B£©¡¢×ܵ¨¹Ì´¼£¨TC£©ºÍ·Ç¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼£¨non-HDL-C£©¡£
¼ÁÐ͹æ¸ñ£º±¾Æ·ÊdzÎÇå¡¢ÎÞÉ«»òµ­»ÆÉ«×¢ÉäÒº£¬1ml/Æ¿»òÖ§£¬200mg/ml£¬200mg/ÖÜ£¬½öÓÃÓÚÆ¤ÏÂ×¢Éä¡£
»îÐԳɷ֣ºMipomersen sodium¡£Mipomersen sodiumÊÇÒ»ÖֺϳɵÄÁò´úÁ×Ëá¹ÑºËÜÕËᣨphosphorothioate oligonucleotide£©ÄÆÑΣ¬20¸öºËÜÕË᳤¶È£¬ÆäÐòÁÐΪ5¡¯-GCCUCAGTCTGCTTCGCACC-3¡¯£¨Ï»®Ïß±íʾ2¡¯-O-(¼×ÑõÒÒ»ù)ºËÜÕËᣬËùÓвлù¾ùΪ2¡¯-ÍÑÑõºËÜÕËᣩ¡£

×÷ÓûúÀí£ºMipomersenÊÇÒ»ÖÖ·´Òå¹ÑºËÜÕËᣬÄܹ»ÓëApo B-100µ°°×mRNAµÄ±àÂëÇø»¥²¹Åä¶Ô£¬ÒÖÖÆApo B-100µ°°×£¨LDLºÍVLDLµÄÖ÷ÒªÔØÖ¬µ°°×£©µÄ·­ÒëºÏ³É¡£
ºÚ¿ò¾¯¸æ£ºÑªÇåת°±Ã¸£¨ALT (alanine aminotransferase)ºÍ/»òAST (aspartate aminotransferase)£©Éý¸ß£¨4% ALT¡Ý3x ULN (upper limit of normal); 3% ALT¡Ý5x ULN£©¡¢Ö¬·¾¸Î£¨hepatic steatosis£©¡£
²»Á¼·´Ó¦£º×¢É䲿λ·´Ó¦°üÀ¨ºì°ß£¨59%£©¡¢ÌÛÍ´£¨56%£©¡¢ÑªÖ×£¨32%£©¡¢É¦Ñ÷£¨29%£©¡¢Ö×ÕÍ£¨18%£©¡¢±äÉ«£¨17%£©£»Á÷¸ÐÑùÖ¢×´°üÀ¨·¢ÈÈ¡¢º®²ü¡¢¼¡Í´¡¢¹Ø½ÚÌÛÍ´¡¢ÐÄÉñ²»°²¡¢·¦Á¦µÈ£¨30%£©£»ÃâÒßÔ­ÐÔ£¨ÓÃÒ©6¸öÔºó£¬38%»¼Õß¼ì²âµ½¿¹Ì壩¡£
2Â¥2013-02-16 11:23:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


¿¹°©Ò©£ºPomalyst (Pomalidomide)½ºÄÒ£¨2013-02-08£©
ÉÌÆ·Ãû£ºPomalyst  Í¨ÓÃÃû£ºPomalidomide  ÖÐÎÄÃû£ºÎ´Öª
ÉóÅú·ÖÀࣺδ֪
Ò©Æó£ºCelgene
ÊÊÓ¦Ö¢£ºÓÃÓÚÖÎÁÆÆäËüÒ©ÎÈçÀ´ÄǶȰ·¡¢ÅðÌæ×ôÃ×£©ÎÞЧµÄ¶à·¢ÐÔ¹ÇËèÁö£¨Multiple Myeloma£©¡£
¼ÁÐ͹æ¸ñ£º±¾Æ·Îª¿Ú·þ½ºÄÒ£¬ÓÐ1mg¡¢2mg¡¢3mg¡¢4mgËÄÖÖ¹æ¸ñ£¬Ó¡ÓÐPOML×ÖÑù¼°¹æ¸ñ¡£4mg/Ì죬·¹Ç°»ò·¹ºó2Сʱ·þÓ㬺ÍË®·þÏ£¬²»ÒªÅªÆÆ¡¢¾×½À»ò´ò¿ª½ºÄÒ¡£
»îÐԳɷ֣ºPomalidomide¡£Pomalidomideº¬Ò»¸öÊÖÐÔ̼ԭ×Ó£¬±¾Æ·Ê¹ÓÃÍâÏûÐý»ìºÏÎΪ»ÆÉ«¹ÌÌå·ÛÄ©¡£

×÷ÓûúÀí£ºPomalidomideɳÀû¶È°·ÀàËÆÎ¾ßÓп¹Ö×Áö»îÐÔ£¬Äܹ»ÒÖÖÆÔìѪÖ×Áöϸ°ûÔöÉú²¢ÓÕµ¼Ï¸°ûµòÍö¡£ÁíÍ⣬PomalidomideÄÜÒÖÖÆÄÍÀ´ÄǶȰ·µÄ¶à·¢ÐÔ¹ÇËèÁöϸ°ûÖêÔöÉú£¬ÄÜÓëµØÈûÃ×ËÉЭͬÓÕµ¼Ö×Áöϸ°ûµòÍö¡£Pomalidomide»¹ÄÜÔöÇ¿Tϸ°ûºÍ×ÔȻɱÉËϸ°û½éµ¼µÄÃâÒß·´Ó¦£¬Í¬Ê±ÒÖÖÆµ¥ºËϸ°û²úÉú´ÙÑ×ÐÔϸ°ûÒò×Ó£¨ÈçTNF-¦Á¡¢IL-6£©¡£
ºÚ¿ò¾¯¸æ£ºÅßÌ¥-Ì¥¶ù¶¾ÐÔ¡¢¾²ÂöѪ˨¡¢ÑªÒº¶¾ÐÔ¡¢¹ýÃô·´Ó¦¡¢Í·ÔΣ¨18%£©¡¢¾«Éñ´íÂÒ£¨12%£©¡¢Éñ¾­²¡±ä£¨18%£©¡¢µÚ¶þÔ­·¢ÐÔ¶ñÐÔÖ×Áö·çÏÕ¡£
²¹³ä˵Ã÷£ºPomalidomideÊǼÌɳÀû¶È°·£¨Thalidomide£©¡¢À´ÄǶȰ·£¨Lenalidomide£©ºóµÚÈý¸ö¶È°·ÀàÒ©ÎÖ÷ÒªÓÃÓÚ¶ÔÀ´ÄǶȰ·¡¢ÅðÌæ×ôÃ×ÄÍÒ©µÄ»¼Õߣ¬Ö®Ç°ÓÚ2012Ä꣬FDAÅú×¼ÁËOnyx¹«Ë¾µÄµ°°×øÌåÒÖÖÆ¼Á¿¨·Ç×ôÃ×£¨Carfilzomib£©ÓÃÓÚÖÎÁƶ෢ÐÔ¹ÇËèÁöµÄÖÎÁÆ¡£
3Â¥2013-02-16 11:26:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÎÞÃû¿ÉÈ¡33

ľ³æ (ÕýʽдÊÖ)

ËÍÏÊ»¨Ò»¶ä
²»´í
רҵDZˮ
4Â¥2013-02-16 23:33:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hardee

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

´Ë²ÝÓÐÖ÷~

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
FDA½ñÄêµÄÊÆÍ·»¹ÊǺÜÃͰ¡
°²µÃ´ÙÏ¥£¬¿É¹²Æ½Éú¡£
5Â¥2013-02-17 09:07:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

arrow6911

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¸±½ÌÊÚ

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
FDA½ñÄêµÄÊÆÍ·ºÜÃÍ..........
iamcoming!
6Â¥2013-02-19 09:28:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

394128

½ð³æ (ÖøÃûдÊÖ)

ÎÒÊÇÒ»¸öÏàÐŰ®ÇéµÄÈË£¬Å¬Á¦ÕõǮֻÊDz»Ï£ÍûÎҵİ®ÇéÊܵ½±ðÈ˽ðÇ®µÄ¿¼Ñé°ÕÁË¡£
7Â¥2013-02-19 21:17:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

snowboy1328

Òø³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÄúºÃ£¡×î½üÔÚÐÐÁÐÍ¡ÀàÒ©ÎïµÄ×ÛÊö£¬ËùÒÔÎÊһϣ¬TeneligliptinÔÚÄĸö¹ú¼ÒÉÏÊÐÁË¡¢ÉÏÊÐÈÕÆÚ£¿Ð»Ð»
8Â¥2013-02-25 10:29:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
лл·ÖÏí
9Â¥2013-08-22 09:55:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ³ÕÃÎäìÏæ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÎÄѧ·¼²ÝÔ°] »ï°éÃÇ£¬×£ÎÒÉúÈÕ¿ìÀÖ°É +17 myrtle 2026-03-10 26/1300 2026-03-16 18:32 by Çà³ÈLn
[¿¼ÑÐ] 333Çóµ÷¼Á +3 ÎÄ˼¿Í 2026-03-16 7/350 2026-03-16 18:21 by ÎÄ˼¿Í
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +6 ´ó¿Édigkids 2026-03-16 6/300 2026-03-16 17:16 by barlinike
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 085600µ÷¼Á +5 ÑúÑú123sun 2026-03-12 6/300 2026-03-16 15:58 by ÑúÑú123sun
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çó¸÷λÀÏʦÊÕÁô +8 ÇïÓÐľ±± 2026-03-14 8/400 2026-03-16 15:21 by ŶŶ123
[½Ìʦ֮¼Ò] ½¹ÂÇ +7 Ë®±ùÔÂÔÂÒ°Íà 2026-03-13 9/450 2026-03-16 10:00 by Quakerbird
[¿¼ÑÐ] 311Çóµ÷¼Á +6 ¶¬Ê®Èý 2026-03-15 6/300 2026-03-16 08:00 by wang_dand
[»ù½ðÉêÇë] NSFCÉ걨ÊéÀïÉêÇëÈ˼òÀúÖдú±íÐÔÂÛÖø»¹ÐèÒªÔÚÉ걨Êé×îºóµÄ¸½¼þÀïÃæÔÙÉÏ´«Ò»±éÂð 20+5 NSFC2026ÎÒÀ´ÁË 2026-03-10 14/700 2026-03-15 23:53 by ²»¸ºÉØ»ªµÄ»¢
[¿¼ÑÐ] 26¿¼ÑÐÒ»Ö¾Ô¸ÖйúʯÓÍ´óѧ(»ª¶«)305·ÖÇóµ÷¼Á +3 ¼ÎÄêÐÂ³Ì 2026-03-15 3/150 2026-03-15 13:58 by ¹þ¹þ¹þ¹þºÙºÙºÙ
[¿¼ÑÐ] 255Çóµ÷¼Á +3 Àî¼Î»Û£¬ 2026-03-12 4/200 2026-03-14 16:58 by ÓÐÖ»ÀêÅ«
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] 308 085701 ËÄÁù¼¶ÒѹýÇóµ÷¼Á +7 ÎÂÇÇÇÇÇÇÇÇ 2026-03-12 14/700 2026-03-14 10:49 by JourneyLucky
[¿¼ÑÐ] 307Çóµ÷¼Á +7 ³¬¼¶ÒÁ°º´óÍõ 2026-03-10 7/350 2026-03-14 00:49 by JourneyLucky
[¿¼ÑÐ] bÇø»·¾³¹¤³ÌÇóµ÷¼Á +4 Maps1 2026-03-10 6/300 2026-03-14 00:23 by JourneyLucky
[¿¼ÑÐ] 279Çóµ÷¼Á +3 Dizzy123@ 2026-03-10 3/150 2026-03-13 23:02 by JourneyLucky
[¿¼ÑÐ] £¨081700£©»¯Ñ§¹¤³ÌÓë¼¼Êõ-298·ÖÇóµ÷¼Á +12 11À²À²À² 2026-03-11 35/1750 2026-03-13 21:25 by JourneyLucky
[¿¼ÑÐ] ¡¾0856¡¿»¯Ñ§¹¤³Ì£¨085602£©313 ·Ö£¬±¾¿ÆÑ§¿ÆÆÀ¹ÀAÀàԺУ»¯Ñ§¹¤³ÌÓ빤ÒÕ£¬³ÏÇóµ÷¼Á +7 СÁõ¿ì¿ìÉϰ¶ 2026-03-11 7/350 2026-03-13 16:06 by ruiyingmiao
[¿¼²©] 2026Ä격ʿÉêÇë +3 QwQwQW10 2026-03-11 3/150 2026-03-12 17:58 by gxch43
[¿¼ÑÐ] ¹þ¹¤´ó²ÄÁÏ324Çóµ÷¼Á +6 ãÆÐñ¶« 2026-03-10 8/400 2026-03-10 22:49 by ÐÇ¿ÕÐÇÔÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û